SAN DIEGO, Oct. 3, 2019 /PRNewswire/ -- Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP), announced today positive data demonstrating that its novel cannabidiol-based therapeutic approach successfully reduces rheumatoid arthritis in an animal model. The data disclosed today, which is the subject of a United States patent applica

NEW YORK, Oct. 3, 2019 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today it has entered into an exclusive distribution agreement for its non-opioid me

LOUISVILLE, Ky. and TAMPA, Fla., Oct. 3, 2019 /PRNewswire/ -- A pilot program in eastern Kentucky designed to remove barriers to healthcare services has shown promising results, including a reduction in emergency room (ER) visits and hospital admissions among a group of nearly 2,000 rural Kentuckians.

BAUDETTE, Minn., Oct. 3, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the receipt of clinical data on Cortrophin® Gel (80 units/mL) from a study that evaluated the blood-level cortisol response in a 20-person healthy volunteer population.  Key results:The results indicate that ANI'

SOUTH SAN FRANCISCO, Calif., Oct. 3, 2019 /PRNewswire/ -- Tenaya Therapeutics, Inc., a company with a mission to discover, develop, and deliver curative therapies that target the underlying causes of heart disease, today announced the successful completion of a $92 million Series B financing.

The Global Cannabis Pioneer Will Have Access to a Broad Spectrum of Strainprint's Product Suite for Medical Cannabis Treatment Support and Product Optimization TORONTO, Oct. 3, 2019 /PRNewswire/ - StrainprintR Technologies Ltd. (Strainprint), the leader in cannabis data and analytics is pleased to expand their international r

SAN DIEGO, Oct. 3, 2019 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable informat

BALTIMORE, Oct. 3, 2019 /PRNewswire/ -- Today, Senior Helpers®, the nation's premier provider of in-home senior care, announced the unveiling of the first

SCHLIEREN, Switzerland and SAN FRANCISCO, Oct. 3, 2019 /PRNewswire/ -- Akero Therapeutics and InSphero AG today announced that Akero has selected InSphero's 3D InSight™ Human Liver Disease Platform to characterize the physiological effects of AKR-001 in different types of liver cells. AKR-001 is designed to be a novel, lon

MINNEAPOLIS, Oct. 3, 2019 /PRNewswire/ -- Today, Bright Health announced it has partnered with University Hospitals to offer Medicare Advantage plans to residents of the Cleveland and Akron areas in 2020. The company will also continue offering Medicare Advantage plans in Cincinna